These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39243022)

  • 21. Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.
    Kim HK; Lee EJ; Lee YJ; Kim J; Kim Y; Kim K; Lee SW; Chang S; Lee YJ; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
    J Hum Genet; 2020 Mar; 65(3):209-220. PubMed ID: 31907386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variant classification changes over time in BRCA1 and BRCA2.
    Mighton C; Charames GS; Wang M; Zakoor KR; Wong A; Shickh S; Watkins N; Lebo MS; Bombard Y; Lerner-Ellis J
    Genet Med; 2019 Oct; 21(10):2248-2254. PubMed ID: 30971832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.
    Bassi N; Hovland HN; Rasheed K; Jarhelle E; Pedersen N; Mchaina EK; Bakkan SME; Iversen N; Høberg-Vetti H; Haukanes BI; Knappskog PM; Aukrust I; Ognedal E; Van Ghelue M
    BMC Cancer; 2023 Apr; 23(1):368. PubMed ID: 37085799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.
    Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
    Clin Genet; 2015 Dec; 88(6):523-9. PubMed ID: 25640009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort.
    Akter H; Sultana N; Martuza N; Siddiqua A; Dity NJ; Rahaman MA; Samara B; Sayeed A; Basiruzzaman M; Rahman MM; Rashidul Hoq M; Amin MR; Baqui MA; Woodbury-Smith M; Uddin KMF; Islam SS; Awwal R; Berdiev BK; Uddin M
    BMC Med Genet; 2019 Sep; 20(1):150. PubMed ID: 31477031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from "Uncertain Significance" to "Pathogenic" based on minigene assays and clinical evidence.
    Ning Y; Zhang Y; Tian T; Chen Y; Wang J; Lei K; Cui Z
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):62. PubMed ID: 38300310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
    Liu Y; Wang H; Wang X; Liu J; Li J; Wang X; Zhang Y; Bai Z; Zhou Q; Wu Y; Shen Y; Weng X; Liu F; Guo J; Di L; Gires O; Zhang Z; Chen Y; Wang H
    J Hematol Oncol; 2021 Jan; 14(1):18. PubMed ID: 33461583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
    Li D; Shi Y; Li A; Cao D; Su H; Yang H; Zhi Q; Yang Y; Lan Z; Zhou T; You X; Hu G
    Breast Cancer; 2020 Nov; 27(6):1158-1167. PubMed ID: 32566972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of renovo predictions on variants reclassified over time.
    Bonetti E; Tini G; Mazzarella L
    J Transl Med; 2024 Jul; 22(1):713. PubMed ID: 39085881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Identification of Deleterious
    Tam B; Sinha S; Qin Z; Wang SM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of genomic germline variant reclassification on clinical cancer care.
    Slavin TP; Manjarrez S; Pritchard CC; Gray S; Weitzel JN
    Oncotarget; 2019 Jan; 10(4):417-423. PubMed ID: 30728895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reclassification of
    Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
    J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic, Surgical and Oncological Approach to Breast Cancer, with
    Subaşıoğlu A; Güç ZG; Gür EÖ; Tekindal MA; Atahan MK
    Eur J Breast Health; 2023 Jan; 19(1):55-69. PubMed ID: 36605468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tracking evolution of BRCA1-associated breast cancer.
    Jonkers J
    Cancer Discov; 2012 Jun; 2(6):486-8. PubMed ID: 22684454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
    Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
    JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
    Eccles DM; Mitchell G; Monteiro AN; Schmutzler R; Couch FJ; Spurdle AB; Gómez-García EB;
    Ann Oncol; 2015 Oct; 26(10):2057-65. PubMed ID: 26153499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.
    Lyra PCM; Nepomuceno TC; de Souza MLM; Machado GF; Veloso MF; Henriques TB; Dos Santos DZ; Ribeiro IG; Ribeiro RS; Rangel LBA; Richardson M; Iversen ES; Goldgar D; Couch FJ; Carvalho MA; Monteiro ANA
    Genet Med; 2021 Feb; 23(2):306-315. PubMed ID: 33087888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel.
    Mester JL; Ghosh R; Pesaran T; Huether R; Karam R; Hruska KS; Costa HA; Lachlan K; Ngeow J; Barnholtz-Sloan J; Sesock K; Hernandez F; Zhang L; Milko L; Plon SE; Hegde M; Eng C
    Hum Mutat; 2018 Nov; 39(11):1581-1592. PubMed ID: 30311380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
    Parsons MT; Tudini E; Li H; Hahnen E; Wappenschmidt B; Feliubadaló L; Aalfs CM; Agata S; Aittomäki K; Alducci E; Alonso-Cerezo MC; Arnold N; Auber B; Austin R; Azzollini J; Balmaña J; Barbieri E; Bartram CR; Blanco A; Blümcke B; Bonache S; Bonanni B; Borg Å; Bortesi B; Brunet J; Bruzzone C; Bucksch K; Cagnoli G; Caldés T; Caliebe A; Caligo MA; Calvello M; Capone GL; Caputo SM; Carnevali I; Carrasco E; Caux-Moncoutier V; Cavalli P; Cini G; Clarke EM; Concolino P; Cops EJ; Cortesi L; Couch FJ; Darder E; de la Hoya M; Dean M; Debatin I; Del Valle J; Delnatte C; Derive N; Diez O; Ditsch N; Domchek SM; Dutrannoy V; Eccles DM; Ehrencrona H; Enders U; Evans DG; Farra C; Faust U; Felbor U; Feroce I; Fine M; Foulkes WD; Galvao HCR; Gambino G; Gehrig A; Gensini F; Gerdes AM; Germani A; Giesecke J; Gismondi V; Gómez C; Gómez Garcia EB; González S; Grau E; Grill S; Gross E; Guerrieri-Gonzaga A; Guillaud-Bataille M; Gutiérrez-Enríquez S; Haaf T; Hackmann K; Hansen TVO; Harris M; Hauke J; Heinrich T; Hellebrand H; Herold KN; Honisch E; Horvath J; Houdayer C; Hübbel V; Iglesias S; Izquierdo A; James PA; Janssen LAM; Jeschke U; Kaulfuß S; Keupp K; Kiechle M; Kölbl A; Krieger S; Kruse TA; Kvist A; Lalloo F; Larsen M; Lattimore VL; Lautrup C; Ledig S; Leinert E; Lewis AL; Lim J; Loeffler M; López-Fernández A; Lucci-Cordisco E; Maass N; Manoukian S; Marabelli M; Matricardi L; Meindl A; Michelli RD; Moghadasi S; Moles-Fernández A; Montagna M; Montalban G; Monteiro AN; Montes E; Mori L; Moserle L; Müller CR; Mundhenke C; Naldi N; Nathanson KL; Navarro M; Nevanlinna H; Nichols CB; Niederacher D; Nielsen HR; Ong KR; Pachter N; Palmero EI; Papi L; Pedersen IS; Peissel B; Perez-Segura P; Pfeifer K; Pineda M; Pohl-Rescigno E; Poplawski NK; Porfirio B; Quante AS; Ramser J; Reis RM; Revillion F; Rhiem K; Riboli B; Ritter J; Rivera D; Rofes P; Rump A; Salinas M; Sánchez de Abajo AM; Schmidt G; Schoenwiese U; Seggewiß J; Solanes A; Steinemann D; Stiller M; Stoppa-Lyonnet D; Sullivan KJ; Susman R; Sutter C; Tavtigian SV; Teo SH; Teulé A; Thomassen M; Tibiletti MG; Tischkowitz M; Tognazzo S; Toland AE; Tornero E; Törngren T; Torres-Esquius S; Toss A; Trainer AH; Tucker KM; van Asperen CJ; van Mackelenbergh MT; Varesco L; Vargas-Parra G; Varon R; Vega A; Velasco Á; Vesper AS; Viel A; Vreeswijk MPG; Wagner SA; Waha A; Walker LC; Walters RJ; Wang-Gohrke S; Weber BHF; Weichert W; Wieland K; Wiesmüller L; Witzel I; Wöckel A; Woodward ER; Zachariae S; Zampiga V; Zeder-Göß C; ; Lázaro C; De Nicolo A; Radice P; Engel C; Schmutzler RK; Goldgar DE; Spurdle AB
    Hum Mutat; 2019 Sep; 40(9):1557-1578. PubMed ID: 31131967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prioritizing genes for systematic variant effect mapping.
    Kuang D; Truty R; Weile J; Johnson B; Nykamp K; Araya C; Nussbaum RL; Roth FP
    Bioinformatics; 2021 Apr; 36(22-23):5448-5455. PubMed ID: 33300982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.